JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
BCRX - Biocryst Pharmaceuticals Inc.
USD | NASDAQ | Healthcare
Summary
Summary BCRX Stock
Financials
Financials BCRX Stock
Loading...
Loading...
Income Statement
Income Statement BCRX Stock
Balance Sheet
Balance Sheet BCRX Stock
Cash Flow Statement
Cash Flow Statement BCRX Stock
Loading...
Loading...
BCRX Financials - Biocryst Pharmaceuticals Income & Cash Flow | Ledgeburg
Home
Stocks
Biocryst Pharmaceuticals Inc. (BCRX)
Financials
Financials of BCRX
Loading...
Loading...
Loading...
Loading...
Revenue
$874.837M
Operating Income
$340.989M
Net Income
$263.861M
Share Count (Basic)
209.893M
Operating Cash Flow
$347.369M
Free Cash Flow
$344.901M
Cash And Short-Term Equivalents
$274.747M
Total Debt
$0
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
100M
200M
300M
400M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-200M
-100M
0
100M
200M
300M
Annual
Quarterly
Margins
Gross
Operating
Net
-100%
-50%
0%
50%
100%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-800M
-600M
-400M
-200M
0
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-400%
-200%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26